Details for New Drug Application (NDA): 203594
✉ Email this page to a colleague
The generic ingredient in DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM is drospirenone; ethinyl estradiol; levomefolate calcium. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.
Summary for 203594
Tradename: | DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM |
Applicant: | Watson Labs Inc |
Ingredient: | drospirenone; ethinyl estradiol; levomefolate calcium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG | ||||
Approval Date: | Oct 11, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription